Skip to main content
. 2022 Mar 3;36(2):1030–1034. doi: 10.21873/invivo.12798

Table II. Clinical outcomes of combination treatment with immune checkpoint inhibitors in patients with renal cell carcinoma and inferior vena cava tumour thrombi.

graphic file with name in_vivo-36-1032-i0001.jpg

ICI: Immune checkpoint inhibitor; IVC: inferior vena cava; RN: radical nephrectomy.